Oklo's Groves Reactor Hits Criticality in Under a Year, a First for DOE Pilot Program
OKLO sits 19% above its 52-week low of $36.61.
Summary
Oklo's Groves Isotope Test Reactor achieved first criticality — a controlled, self-sustaining nuclear chain reaction — less than a year after breaking ground on a greenfield site in Texas. This is the first reactor under the DOE's Reactor Pilot Program to reach this milestone on private land, built from scratch. The achievement validates Oklo's in-house design, construction, and fuel procurement capabilities, and sets a new speed benchmark for advanced nuclear deployment. It follows the DOE's startup authorization in late July and the final safety analysis approval earlier that month. The reactor is designed to enable domestic radioisotope production for healthcare, industry, and space applications, while also derisking future commercial powerhouse deployments. Despite the technical breakthrough, shares traded flat near 52-week lows, reflecting ongoing market skepticism or dilution overhang from the active $1B ATM program.
At the time of this announcement, OKLO was trading at $43.49 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $36.61 to $193.84. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Benzinga.